MLHP 106 Hematology and Transfusion Science - Lesson 5 NOTES & Flashcards

Transfusion Medicine and Blood Bank: Core Concepts and Practice

Transfusion Medicine, also known as Immunohematology, is the branch of medicine concerned with the collection (donation), testing, processing, storing, and transfusion of blood and its components. The field encompasses laboratory techniques used in the Transfusion Lab, understanding blood groups (ABO and Rh), antibody screening and identification, and the equipment and procedures that ensure safe transfusion practice. The overarching aim is to ensure compatibility between donor and recipient blood to minimize transfusion reactions and maximize patient safety.

Basic Definitions and Roles

Transfusion: the transfer of blood or blood products from donor to recipient. A Donor is someone who gives blood, while a Recipient is someone who receives blood or blood products. Antigen refers to Red Blood Cell (RBC) antigens on the surface of RBCs (may be sugars or proteins). An Antibody is a protein in plasma formed against specific antigens; exposure to a foreign antigen triggers an immune response that produces antibodies. Antiserum is commercially prepared serum containing known antibodies used to test for red cell antigens. Naturally Occurring Antibody examples include anti-A and anti-B, which are produced without prior stimulation by an A or B antigen, respectively. Phenotyping tests RBCs for the presence or absence of antigens. Agglutination is visible clumping caused by an antigen–antibody reaction. Frozen Plasma (FP) is plasma obtained from whole blood and frozen after separation, containing plasma only.

Key components and processes include Components (RBCs, Plasma, Platelets, and other plasma products rich in coagulation factors), Cross-match testing (donor RBCs with patient plasma to assess compatibility), Antibody Screen (to detect antibodies other than ABO/Rh), and Antibody Identification (to determine the identity of a red cell antibody if screened positive).

Leukoreduction is the process of filtering whole blood to remove white blood cells (leukocytes) before storage or transfusion.

Blood Donation and Donor Testing

Blood donation follows World Health Organization guidelines: donors should be at low risk for transfusion-transmissible infections and should not jeopardize their own health by donation. Donations are tested for infectious agents with multiple screening tests and ABO/Rh typing, along with other red cell antigens and antibodies, to reduce the risk of transfusion reactions due to incompatibility.

CBS (Canadian Blood Services) conducts transfusion-transmissible disease testing including Hepatitis A, B, and C; Cytomegalovirus; HIV types 1 and 2; HTLV-I and II; West Nile virus, among others. The most commonly prepared components from CBS are Red Blood Cells (RBC), Platelets (PLTS), and Frozen Plasma (FP). Other plasma products include Cryosupernatant Plasma (CSP) and Cryoprecipitate. In standard blood donation, the collected volume is approximately 450 mL450\ \text{mL}.

All manufactured blood components released for hospital use carry a standard format label. Proper storage and transportation are critical to safe transfusion and to preserve component efficacy; improper storage can lead to bacterial contamination or reduced efficacy. The typical storage conditions and considerations include:

  • Red Blood Cells are stored at 1−6∘C1-6^\circ\text{C} with continuous monitoring, and have a shelf life of 42 days42\ \text{days} from collection. The expiry date is on the unit label. RBC shelf life is reduced to a maximum of 4 hours4\ hours if stored above 6∘C6^\circ\text{C}. Transportation time should not exceed 27 hours27\ \text{hours} using validated packing procedures that maintain 1–6°C.

  • Whole blood is collected into CPD anticoagulant bags; whole blood is separated into RBCs (packed RBCs), Platelets, and Plasma (FFP). SAGM (Saline-Adenine-Glucose-Mannitol) is added for RBC storage to protect the RBC membrane and reduce hemolysis.

  • Leukoreduction is performed on all manufactured blood components.

  • Platelets are stored at 20−24∘C20-24^\circ\text{C} with continuous agitation, and have a shelf life of 7 extdays7\ ext{days} from collection. Platelets are pooled from multiple donors (usually 4 different donors) to form a single pooled unit; the pool is leukoreduced and assigned a unique pool number. Platelet products are prepared within 28 hours28\ \text{hours} of collection.

  • Plasma components include FP and CSP. FP is frozen plasma prepared from whole blood collected in CPD, with RBCs and WBCs reduced. FP is stored frozen at −18∘C-18^\circ\text{C} or colder for up to 12 extmonths12\ ext{months} and must not be out of a temperature-controlled freezer for more than 30 extminutes30\ ext{minutes}. Cryoprecipitate also requires freezing at −18∘C-18^\circ\text{C} or colder with a 12‑month maximum storage; once thawed, it should be stored at 20−24∘C20-24^\circ\text{C} and used within 4 hours4\ hours.

  • All blood products are labeled with standard information and must be stored and transported under validated conditions to maintain traceability from donor to final disposition.

ABO and Rh Blood Group Systems

Immunohematology centers on classifying blood groups and ensuring compatibility. The ABO system is the major blood group system. Karl Landsteiner discovered the ABO blood groups in 1900. Four major types exist: A, B, AB, and O, determined by the presence or absence of A and B antigens on RBCs.

  • Group A: A antigen present; anti-B antibodies in plasma.

  • Group B: B antigen present; anti-A antibodies in plasma.

  • Group AB: Both A and B antigens present; no anti-A or anti-B antibodies in plasma (universal recipient for ABO incompletely, but not universally safe with Rh).

  • Group O: Neither A nor B antigens present; both anti-A and anti-B antibodies present in plasma.

ABO testing uses forward grouping (RBCs + antisera to detect antigens) and reverse grouping (plasma + known antigen cells to detect antibodies). ABO testing can be performed by tube, slide, or gel methods; tube and gel methods are generally more sensitive than slide methods. The presence of ABO antigens and corresponding antibodies determines compatibility before transfusion. Table-based and diagrammatic representations illustrate forward and reverse grouping results, including common reaction patterns for each blood type.

Rh (D) system is the second most important blood group system. Red cells with the D antigen are Rh-positive; those lacking D are Rh-negative. Rh antibodies are not naturally occurring; anti-D can develop upon exposure (transfusion of Rh-positive blood to an Rh-negative person or maternal-fetal exposure). Rh Immune Globulin (RhIG) is given to Rh-negative pregnant women at risk of fetal-metal Rh exposure to prevent anti-D formation.

Universal donors/recipients: O− RBCs are universal donors (can be given to patients of any ABO type), while AB+ patients are universal recipients (can receive RBCs from any ABO type). In transfusion medicine, ABO and Rh testing precede any compatibility assessments aimed at preventing transfusion reactions.

Antibody Screening, Identification, and Other Blood Group Systems

Beyond ABO and Rh, there are more than 200 known antibodies against red cell antigens across about 29 blood group systems. Antibody screens detect the presence of antibodies against non-ABO/Rh antigens. If a screen is positive, antibody identification follows to determine which antigen the antibody targets. In such cases, donor units are phenotyped to avoid providing antigen-positive blood to the patient. The testing for other blood group systems (OBG) is routine and critical for patients with identified antibodies.

Positive antibody screens require specialized cross-matching procedures to ensure donor units lack the corresponding antigens. The presence of clinically significant antibodies necessitates careful donor selection and additional testing to achieve compatibility.

Laboratory Equipment in the Blood Bank

Key equipment includes:

  • Serological Centrifuge: designed for high-quality blood grouping and typing in a variety of tube sizes.

  • Dry Heat Blocks: used to heat or maintain specific temperatures during specialized transfusion testing (many tests are performed at 37°C).

  • Cell Washers: remove plasma, platelets, and white blood cells from a drop of whole blood; can be manual or automated.

  • Microtyping System: used for antibody screening and identification; the gel method involves incubation and centrifugation of gel cards.

    • Process: add patient plasma and RBCs, incubate at 37°C, place card into microtyping system, centrifuge, and observe for agglutination.

  • Incubators and Centrifuges for microtyping cards.

Equipment also includes an alarm system and recorder for refrigeration equipment, with precise temperature controls and safety features.

Storage, Transportation, and Handling of Blood Components

Storage and transportation are critical to maintaining component viability and patient safety. Red blood cell units have a shelf life of 42 days42\ \text{days} from collection when stored at 1−6∘C1-6^\circ\text{C}. If above 6°C, shelf life is effectively reduced to a smaller window (4 hours after removal from storage is stated as a rule under certain conditions). RBCs must be transported in validated containers, designed to preserve 1–6°C with traceable records.

Platelets require storage at 20−24∘C20-24^\circ\text{C} with continuous agitation and must be used within 7 extdays7\ ext{days} from collection. Pooled platelets are created from multiple donors (typically 4), Leukoreduced, and assigned a pool number. Platelet products are produced within 28 hours28\ \text{hours} of collection.

Frozen plasma products (FP) are prepared from whole blood collected in CPD, leukoreduced, and stored at or below −18∘C-18^\circ\text{C} for up to 12 extmonths12\ ext{months}. FP and CSP must not be out of a temperature-controlled storage freezer for longer than 30 extminutes30\ ext{minutes}. Cryoprecipitate is stored similarly and must not be refrozen after thawing; once thawed, it should be used within 4 hours4\ hours at 20−24∘C20-24^\circ\text{C}.

Proper labeling, traceability, and adherence to storage guidelines are essential to maintaining transfusion safety.

Transfusion Reactions, Risks, and Error Prevention

Most common errors in transfusion medicine include mislabeling specimens, collecting from the wrong patient, improper blood grouping, and giving the wrong unit of blood to the wrong patient. The consequences can be severe, including immediate transfusion reactions, with potential for death. Acute hemolytic reactions may present with respiratory distress, fever, hypotension, and hemoglobinuria, and disseminated intravascular coagulation (DIC) can occur, leading to both clotting and bleeding. Preventing these errors relies on strict specimen labeling, accurate patient identification, careful ABO/Rh typing, and proper cross-matching.

Specimen handling and labeling are critical; if labeling is incorrect or the specimen is unlabeled, testing is halted and re-collection is required, which delays patient treatment. Blood bank specimens require strict patient identification and labeling procedures. EDTA tubes (lavender or pink tops) are standard for testing; additional tubes may be used for special tests. Samples must be refrigerated at 1–10°C for storage and 7 days post-transfusion for traceability. Plasma can be separated and frozen for longer-term storage (up to 3 months).

Practical Checkpoints and Study Prompts

  • CBS stands for Canadian Blood Services. The three most commonly prepared components from one whole blood donation are Red Blood Cells, Platelets, and Frozen Plasma. The anticoagulant in whole blood collection bags is CPD (citrate-phosphate-dextrose).

  • RBC units (packed RBCs) are stored at 1–6°C with a 42-day shelf life; the RBC unit expiry date is on the label.

  • Platelets require agitation, storage at 20–24°C, and have a 7-day shelf life; pooled platelets come from four donors and are leukoreduced.

  • FP and CSP storage is at -18°C or colder for up to 12 months; FP/CSP should not be out of the temperature-controlled freezer for more than 30 minutes; cryoprecipitate thawed and stored at 20–24°C must be transfused within 4 hours.

  • ABO forward grouping uses RBCs with antisera to detect A and B antigens; reverse grouping uses patient plasma with known A and B cells to detect antibodies. Reactions should be opposite in forward and reverse groupings.

  • The Rh system’s D antigen determines Rh status (Rh+ vs Rh−). Anti-D antibodies are not naturally occurring; they can form after exposure. RhIg (Rho(D) Immunoglobulin) is given at 28 weeks gestation to prevent anti-D formation in Rh− mothers.

  • Universal donors and recipients are O− and AB+ respectively for RBC transfusion; however, all transfusions must still be matched for safety.

  • More than 200 RBC antigens are recognized across about 29 blood group systems; most OB systems antibodies are not naturally occurring, and antibody screening is routinely performed.

  • Equipment in the Blood Bank supports serology and molecular approaches to determine compatibility and detect antibodies.

Ethical, Philosophical, and Practical Implications

Ethical considerations center on donor safety, patient safety, informed consent, and the equitable allocation of blood products. The necessity to minimize risk of transfusion reactions, balance donor exposure with patient need, and ensure rapid accessibility to compatible blood for emergencies are fundamental. Practically, robust systems for labeling, traceability, and rapid cross-matching are essential to prevent fatal errors. The use of leukoreduction, controlled storage environments, and validated transport protocols reflects a comprehensive safety culture in transfusion medicine.

Summary and Formulas (LaTeX)

  • Shelf life of Red Blood Cells: 42 days42\ \text{days}

  • Storage temperature for RBCs: 1−6∘C1-6^\circ\text{C}

  • Transportation time for RBCs: 27 hours27\ \text{hours}

  • RBC expiry if stored above 6°C: 4 hours\text{4 hours} (approximate operational window)

  • Platelet storage: 20−24∘C20-24^\circ\text{C} with agitation; shelf life 7 days7\ \text{days}

  • Platelet pooling: from 4 donors4\ donors; pool time within 28 hours28\ \text{hours}

  • FP and CSP storage: −18∘C-18^\circ\text{C} for up to 12 months12\ \text{months}; not out of freezer > 30 minutes30\ \text{minutes}

  • Cryoprecipitate thaw storage: after thaw, at 20−24∘C20-24^\circ\text{C} for 4 hours4\ \text{hours}

  • Universal donor for RBC: O−O^-; universal recipient for RBC: AB+AB^+

Connections to Foundational Principles

  • Immunohematology relies on antigen–antibody interactions, including agglutination and immune responses. The ABO and Rh systems are foundational to safe transfusion practice and are linked to concepts of immune compatibility, alloimmunization, and transfusion medicine ethics.

  • The safety pipeline—from donor screening to component processing, storage, and cross-matching—embodies principles of quality assurance, risk management, and patient safety in clinical laboratory science.

Examples and Hypothetical Scenarios

  • If a patient with blood type O− experiences severe trauma, O− RBCs are used as the initial universal donor product in emergent settings, followed by careful typing and crossmatching as soon as possible.

  • An Rh− pregnant patient requires RhIG at 28 weeks to prevent maternal anti-D formation and potential hemolytic disease of the fetus and newborn (HDFN).

  • A patient with an unexpected positive antibody screen requires antibody identification; donor units must be phenotyped to avoid the corresponding antigen and ensure compatibility.

This set of notes consolidates the key concepts, processes, and practical considerations from the provided transcript, organized into a structured study resource suitable for exam preparation in Transfusion Medicine and Blood Bank.